89 results
Page 3 of 5
8-K
EX-99.1
ril5qypfq46ht z2mm
14 Nov 22
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
8:48am
8-K
EX-99.1
a1q chpsjxbfk96mx
8 Nov 22
Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG
9:13pm
8-K
EX-99.1
a4xovrxw
31 Oct 22
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
4:11pm
8-K
EX-99.1
jfg cupug42
24 Oct 22
Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
8:00am
8-K
EX-99.1
pmc6q clms
14 Oct 22
Entry into a Material Definitive Agreement
8:54am
8-K
EX-99.1
8175qt61rpmezoe6redk
5 Oct 22
Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
5:10pm
DRS
wvhmgcw4
29 Aug 22
Draft registration statement
12:00am
8-K
EX-99.1
mgb70rly
12 Aug 22
Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business Update
9:03am
8-K
EX-99.1
k6b 1xajh3
27 Jul 22
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
9:44pm
8-K
EX-99.1
oq0b p3rnu883yqgpl
12 Jul 22
Biofrontera Inc. Announces Preliminary Product Revenues for the Second
4:13pm
424B3
jzlix93xzmgo3d p1n
9 Jun 22
Prospectus supplement
5:28pm
8-K
EX-99.1
brbjjnz 2j4sajteuzs6
20 May 22
Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
4:30pm
8-K
EX-99.2
haydsxbx4p
20 May 22
Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
4:30pm
424B3
wm5 hub30ifkqn7y
13 May 22
Prospectus supplement
5:29pm
424B3
u22puiafid01 rxmo
13 May 22
Prospectus supplement
5:27pm
8-K
EX-99.1
yl4kch04dvlld34w7k
13 May 22
Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business Update
7:27am